Abstract:Disrupting NMDA receptor signaling by PSD95‐nNOS protein–protein interactions inhibitors blocked morphine‐induced CPP, attenuated morphine‐induced increases in DA efflux and reduced morphine relapse. Glutamate signalling through the N‐methyl‐d‐aspartate receptor (NMDAR) activates the enzyme neuronal nitric oxide synthase (nNOS) to produce the signalling molecule nitric oxide (NO). We hypothesized that disruption of the protein–protein interaction between nNOS and the scaffolding protein postsynaptic density 95 kDa (PSD95) would block NMDAR‐dependent NO signalling and represent a viable therapeutic route to decrease opioid reward and relapse‐like behaviour without the unwanted side effects of NMDAR antagonists. We used a conditioned place preference (CPP) paradigm to evaluate the impact of two small‐molecule PSD95‐nNOS inhibitors, IC87201 and ZL006, on the rewarding effects of morphine. Both IC87201 and ZL006 blocked morphine‐induced CPP at doses that lacked intrinsic rewarding or aversive properties. Furthermore, in vivo fast‐scan cyclic voltammetry (FSCV) was used to ascertain the impact of ZL006 on morphine‐induced increases in dopamine (DA) efflux in the nucleus accumbens shell (NAc shell) evoked by electrical stimulation of the medial forebrain bundle (MFB). ZL006 attenuated morphine‐induced increases in DA efflux at a dose that did not have intrinsic effects on DA transmission. We also employed multiple intravenous drug self‐administration approaches to examine the impact of ZL006 on the reinforcing effects of morphine. Interestingly, ZL006 did not alter acquisition or maintenance of morphine self‐administration, but reduced lever pressing in a morphine relapse test after forced abstinence. Our results provide behavioural and neurochemical support for the hypothesis that inhibition of PSD95‐nNOS protein–protein interactions decreases morphine reward and relapse‐like behaviour, highlighting a previously unreported application for these novel therapeutics in the treatment of opioid addiction.

Synthetic double-stranded RNA polyinosinic-polycytidylic acid augments morphine-induced conditioned place preference in rats.

Effects of polyinosinic-polycytidylic acid (Poly I:C) on naloxone-precipitated withdrawal in morphine-dependent mice.

Interferon-Alpha Reinstates Morphine-Conditioned Place Preference Through Opioid Receptors in Rats

Effect of Intrathecal Morphine and Electro-Acupuncture on Cellular Immune Function of Rats and Increment of Mu-Opioid Receptor Mrna Expression in PAG Following Intrathecal Morphine.

Molecular Chaperone Heat Shock Protein 70 Inhibitors Suppress Conditioned Place Preference Induced by Morphine Exposure in Male Rats.

The differential effects of OX1R and OX2R selective antagonists on morphine conditioned place preference in naïve versus morphine-dependent mice

Intrathecal PLCβ3 oligodeoxynucleotides antisense potentiates acute morphine efficacy and attenuates chronic morphine tolerance

Experimental Study: Interleukin-31 Augments Morphine-Induced Antinociceptive Activity and Suppress Tolerance Development in Mice

Upregulation of HCN2 in ventral tegmental area is involved in morphine‐induced conditioned place preference in rats

Inhibition of PSD95‐nNOS protein–protein interactions decreases morphine reward and relapse vulnerability in rats

The Possible Involvement of Endogenous Ligands for Mu-, Delta- and Kappa-Opioid Receptors in Modulating Morphine-Induced CPP Expression in Rats

The role of NR2B containing NMDA receptor in place preference conditioned with morphine and natural reinforcers in rats.

Transcription and Protein Synthesis Inhibitors Reduce the Induction of Behavioural Sensitization to a Single Morphine Exposure and Regulate Hsp70 Expression in the Mouse Nucleus Accumbens.

Effects of Inhibiting the Expression of Gene Periodl on Morphine-induced Reward and Expression of DBI mRNA in Mice

Influence of l-tetrahydropalmatine on morphine-induced conditioned place preference

Cannabinoid 1 Receptor Blockade in the Dorsal Hippocampus Prevents the Reinstatement but Not Acquisition of Morphine-Induced Conditioned Place Preference in Rats

Transgenic increase in the β-endorphin concentration in cerebrospinal fluid alleviates morphine-primed relapse behavior through the μ opioid receptor in rats.

Blockade of Cannabinoid CB1 Receptor Attenuates the Acquisition of Morphine-Induced Conditioned Place Preference along with a Downregulation of ERK, CREB Phosphorylation, and BDNF Expression in the Nucleus Accumbens and Hippocampus.

Pre-treatment with morphine prevents lipopolysaccharide-induced acute respiratory distress syndrome in rats via activation of opioid receptors

Changes of Protein Expression Profiles in the Amygdala During the Process of Morphine-Induced Conditioned Place Preference in Rats

Plastic changes of calcitonin gene-related peptide in morphine tolerance: behavioral and immunohistochemical study in rats.